Le Lézard
Classified in: Health
Subject: CALENDAR OF EVENTS

Theratechnologies to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference


MONTREAL, April 11, 2024 (GLOBE NEWSWIRE) -- Theratechnologies Inc. ("Theratechnologies" or the "Company") (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of innovative therapies, today announced that the Company's President and CEO, Paul Lévesque will be presenting at the 2024 Bloom Burton & Co. Healthcare Investor Conference, which is taking place April 16-17 in Toronto, Canada.

Presentation Details: 
Date/Time:Wednesday, April 17, 2024, at 10:00 AM ET
Room:104A
Location:Metro Toronto Convention Centre
  

Members of the Theratechnologies management team will also be taking meetings throughout the conference. Further information on the conference, including registration details can be found here.

About Theratechnologies
Theratechnologies (TSX: TH) (NASDAQ: THTX) is a biopharmaceutical company focused on the development and commercialization of innovative therapies addressing unmet medical needs. Further information about Theratechnologies is available on the Company's website at www.theratech.com, on SEDAR at www.sedar.com and on EDGAR at www.sec.gov

Contacts:

Investor inquiries:
Philippe Dubuc
Senior Vice President and Chief Financial Officer
[email protected]
1-438-315-6608

Media inquiries:
Julie Schneiderman
Senior Director, Communications & Corporate Affairs
[email protected]
1-514-336-7800



These press releases may also interest you

at 22:30
Monsanto Wins Appeal Ruling in Erickson v. Monsanto
Today, a decision was issued by the Court of Appeals Division I in the State of Washington in Erickson v. Monsanto, ruling in Monsanto's favor on multiple grounds. This decision reverses the initial verdict of $185 million in its entirety and...

at 21:30
Astellas and Poseida Therapeutics Enter Into Research Collaboration and License Agreement to Develop Novel Allogeneic Cell Therapies in Oncology
Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") and Poseida Therapeutics, Inc.  today announced that Xyphos Biosciences, Inc., (a wholly owned subsidiary of Astellas, "Xyphos") and Poseida have entered into a...

at 21:00
Memorial Regional Hospital Named Florida's First Resuscitation Center of Excellence
Memorial Regional Hospital in Florida has earned the prestigious title of being the state's inaugural Resuscitation Center of Excellence (RCOE), underscoring the hospital's adherence to over 30 evidence-based criteria in providing top-tier cardiac...

at 19:31
Momcozy Announces Collaboration with 1 Natural Way To Provide Accessible Breastfeeding Solutions For New Mothers
Momcozy, a trusted global brand specializing in solution-focused maternal and baby care products since 2018, has announced their collaboration with 1 Natural Way (1NW), a nationally recognized Durable Medical Equipment company catering to the precise...

at 19:01
Integrated cancer biotech Infinitopes secures £12.8m seed financing to enhance its Precision Immunomicstm antigen discovery technologies to target five more cancers
Infinitopes Precision Immunomics, an integrated cancer biotech combining world leading platforms in precision antigen discovery with vaccine vectors capable of durably stimulating protective immune responses, today announced the completion of a...

at 17:49
The ALS Association Kicks Off ALS Awareness Month and Commemorates the 10th Anniversary of the Ice Bucket Challenge
The ALS Association today celebrated the beginning of ALS Awareness Month and the 10th Anniversary of the Ice Bucket Challenge, which inspired the world to join the fight against ALS in the summer of 2014. Throughout May and the summer, the ALS...

More news about Health...


News published on and distributed by: